Among hypoxemic, non-HIV immunocompromised adults with Pneumocystis jirovecii pneumonia (PJP or PCP), greater cumulative corticosteroid (CS) exposure is associated with increased 90-day mortality, according to study findings…
CS Use Linked to Higher 90-Day Mortality in Pneumocystis jirovecii Pneumonia
